These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 7646591

  • 41. Hypoparathyroidism: a possible cause of osteomalacia .
    Drezner MK, Neelon FA, Jowsey J, Lebovitz HE.
    J Clin Endocrinol Metab; 1977 Jul; 45(1):114-22. PubMed ID: 874058
    [Abstract] [Full Text] [Related]

  • 42. Enhancement of ionized calcium and 1,25-dihydroxycholecalciferol loss from peritoneal fluid during peritonitis in patients treated with continuous ambulatory peritoneal dialysis.
    Lin CY, Huang TP.
    Nephron; 1991 Jul; 59(1):90-5. PubMed ID: 1944754
    [Abstract] [Full Text] [Related]

  • 43. Effects of 6 months therapy with 1,25 (OH)2D3 on bone disease of dialysis patients.
    Malluche HH, Goldstein DA, Massry SG.
    Contrib Nephrol; 1980 Jul; 18():98-104. PubMed ID: 7353383
    [No Abstract] [Full Text] [Related]

  • 44. Spot the silent sufferers: A call for clinical diagnostic criteria for solar and nutritional osteomalacia.
    Uday S, Högler W.
    J Steroid Biochem Mol Biol; 2019 Apr; 188():141-146. PubMed ID: 30654108
    [Abstract] [Full Text] [Related]

  • 45. Osteomalacia in a patient with severe anorexia nervosa.
    Oliveri B, Gomez Acotto C, Mautalen C.
    Rev Rhum Engl Ed; 1999 Oct; 66(10):505-8. PubMed ID: 10567980
    [Abstract] [Full Text] [Related]

  • 46. Tumor-related osteomalacia followed after treatment by hyperparathyroidism.
    Heylen A, Dasnoy D, Hustin J, Pochet JM.
    Rev Rhum Engl Ed; 1999 Jan; 66(1):53-7. PubMed ID: 10036701
    [Abstract] [Full Text] [Related]

  • 47. Serum ionized calcium, as well as phosphorus and parathyroid hormone, is associated with the plasma 1,25-dihydroxyvitamin D3 concentration in normal postmenopausal women.
    Dawson-Hughes B, Harris S, Dallal GE.
    J Bone Miner Res; 1991 May; 6(5):461-8. PubMed ID: 2068951
    [Abstract] [Full Text] [Related]

  • 48. Plasma Ca influences vitamin D metabolite levels as rats develop vitamin D deficiency.
    Kollenkirchen U, Walters MR, Fox J.
    Am J Physiol; 1991 Mar; 260(3 Pt 1):E447-52. PubMed ID: 1848406
    [Abstract] [Full Text] [Related]

  • 49. Diagnosing hypovitaminosis D: serum measurements of calcium, phosphate, and alkaline phosphatase are unreliable, even in the presence of secondary hyperparathyroidism.
    Smith GR, Collinson PO, Kiely PD.
    J Rheumatol; 2005 Apr; 32(4):684-9. PubMed ID: 15801026
    [Abstract] [Full Text] [Related]

  • 50. Abnormalities of parathyroid hormone secretion in elderly women that are reversible by short term therapy with 1,25-dihydroxyvitamin D3.
    Ledger GA, Burritt MF, Kao PC, O'Fallon WM, Riggs BL, Khosla S.
    J Clin Endocrinol Metab; 1994 Jul; 79(1):211-6. PubMed ID: 8027229
    [Abstract] [Full Text] [Related]

  • 51. Hypocalcemia, but not PTH or hypophosphatemia, induces a rapid increase in 1,25(OH)2D3 levels in rats.
    Fox J.
    Am J Physiol; 1992 Feb; 262(2 Pt 1):E211-5. PubMed ID: 1539647
    [Abstract] [Full Text] [Related]

  • 52. The effect of 1alpha(OH)D3 and 1alpha,25(OH)2D3 on the bone in patients with renal osteodystrophy.
    Bordier P, Zingraff J, Gueris J, Jungers P, Marie P, Pechet M, Rasmussen H.
    Am J Med; 1978 Jan; 64(1):101-7. PubMed ID: 623125
    [Abstract] [Full Text] [Related]

  • 53. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
    Drezner MK, Lyles KW, Haussler MR, Harrelson JM.
    J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
    [Abstract] [Full Text] [Related]

  • 54. Normal plasma-1,25-(OH)2-vitamin-D concentrations in nutritional osteomalacia.
    Eastwood JB, de Wardener HE, Gray RW, Lemann JL.
    Lancet; 1979 Jun 30; 1(8131):1377-8. PubMed ID: 87836
    [Abstract] [Full Text] [Related]

  • 55. Lack of relationship between parathyroid hormone and 1,25-dihydroxyvitamin D in chronic renal failure.
    Rudnicki M, McNair P, Transbøl I, Nielsen B.
    Nephron; 1991 Jun 30; 58(2):144-9. PubMed ID: 1865969
    [Abstract] [Full Text] [Related]

  • 56. Bone densitometry in a patient with hypophosphatemic osteomalacia.
    Negri AL, Bogado CE, Zanchetta JR.
    J Bone Miner Metab; 2004 Jun 30; 22(5):514-7. PubMed ID: 15316875
    [Abstract] [Full Text] [Related]

  • 57. In vivo regulation of chromogranin A messenger ribonucleic acid in the parathyroid by 1,25-dihydroxyvitamin D: studies in normal rats and in chronic renal insufficiency.
    Soliman E, Canaff L, Fox J, Hendy GN.
    Endocrinology; 1997 Jun 30; 138(6):2596-600. PubMed ID: 9165053
    [Abstract] [Full Text] [Related]

  • 58. Clinical features and detection of osteomalacia in the elderly.
    Rosin AJ.
    Postgrad Med J; 1970 Mar 30; 46(533):131-6. PubMed ID: 5309700
    [Abstract] [Full Text] [Related]

  • 59. Studies in a patient with tumor-induced hypophosphatemic osteomalacia.
    Ryan WG, Gitelis S, Charters JR.
    Calcif Tissue Int; 1986 Jun 30; 38(6):358-62. PubMed ID: 3089559
    [Abstract] [Full Text] [Related]

  • 60. Modulation by retinoic acid of 1,25-dihydroxyvitamin D3 effects on alkaline phosphatase activity and parathyroid hormone responsiveness in an osteoblast-like osteosarcoma cell line.
    Grigoriadis AE, Petkovich PM, Rosenthal EE, Heersche JN.
    Endocrinology; 1986 Aug 30; 119(2):932-9. PubMed ID: 3015560
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.